Heath KM, Elovic EP: Vitamin D deficiency: implications in the rehabilitation setting. Am J Phys Med Rehabil 2006;85:916 -923. Objective: Vitamin D deficiency, which can result from inadequate sun exposure, dietary intake, or problems with absorption, is rarely documented in the rehabilitation literature. Most likely, it is rarely thought of by the rehabilitation profession. This is problematic because vitamin D deficiency can present as musculoskeletal pain, which is commonly seen in both outpatient clinics and inpatient rehabilitation units. The populations with the greatest risk include the homebound elderly, people with pigmented skin, people with cultural and social avoidance of the sun, people who live in wintertime in climates above and below latitudes of 35 degrees, and people with gastrointestinal malabsorption.
Accordi ng to the literature, the incidence of vitamin D deficiency in the general population is 25% in the United States and more than 40% in the elderly population. 1, 2 What is less commonly known, but widely reported in the literature, is that vitamin D deficiency can initially present as musculoskeletal pain, a condition that is seen all too often by rehabilitation professionals in both outpatient clinics and inpatient rehabilitation units. [3] [4] [5] [6] [7] [8] [9] [10] Numerous case studies have shown drastic improvements in musculoskeletal symptoms including back pain when normalizing vitamin D levels. 4, 8, 11 Because the rehabilitation professional is likely to encounter patients with vitamin D deficiency, it is essential to understand the mechanism of deficiency, the population affected, and the potential treatments.
Normally, an adequate supply of vitamin D is obtained from exposure to the sun, with even minimal sun exposure providing 90 -100% of the required vitamin D. 12 Vitamin D deficiency is a twofold problem. The first component is that when sun exposure is limited, dietary intake of vitamin D often falls below the recommended daily allowance (RDA) because vitamin D-rich sources such as eel and cod liver oil are not mainstays in many cultures' diets. The second component is that the current RDA does not assure vitamin D sufficiency. Gloth 13 found that 32% of nursing home patients remained deficient, even when consuming more than 400 IU of vitamin D per day.
The populations that are most at risk are those that have decreased sun exposure. This includes the homebound elderly, people with highly pigmented skin, people who live in wintertime in climates above and below latitudes of 35 degrees, and those whose cultural and societal beliefs limit sun exposure. 14 -22 Another group at risk for vitamin D deficiency is those who have a malabsorption syndrome such as Crohn's disease or gastric stapling. In these cases, vitamin D deficiency is caused by a decrease in absorption in the small intestine. 23 There are numerous signs and symptoms that result from vitamin D deficiency. They include proximal muscle weakness, back pain, and muscle and bone pain. Treating this deficiency resulted in clinical improvement, 4, 7, 8, 10, 24 with studies showing marked increases in strength 5, 8, 11 and patients becoming pain free within 6 mos of treatment with vitamin D. 3, 4 The risk of toxicity resulting from vitamin D replacement therapy is very low. 25 This favorable risk/benefit ratio, coupled with the ubiquity of complaints of weakness and pain in the rehabilitation population, make it incumbent on the rehabilitation physician to be knowledgeable about the diagnosis and treatment of this condition.
METHODS
The articles for review were selected through searches in PubMed, Ovid, and MDConsult using the terms pain, chronic pain, musculoskeletal pain, vitamin D deficiency, and osetomalacia. The search revealed 107 articles, which were narrowed down to 62 relevant articles. Articles rejected from the search were on other manifestations of vitamin D deficiency, review articles on osteomalacia and rickets, or in a language other than English. The abstracts of the 15 articles that were not in English were reviewed. Although nine of these were pertinent, they added no new information to the discussion and were therefore not included. After review of the articles, 51 were included in this review paper. The remaining 11 articles were excluded because they were either review articles or on manifestations of osteomalacia not pertaining to musculoskeletal pain.
The Mechanism of Vitamin D Absorption and Activation
Vitamin D can be absorbed either through the dermis from sunlight or through enteral means via food or vitamin supplements. Once absorbed by the body, vitamin D must first be metabolized by both the liver and the kidney before it reaches its final useable form of calcitriol. The ultraviolet B wavelengths between 290 and 315 nm are the most important when vitamin D is absorbed through the dermis. In the epidermis, precursor 7-dehydrocholesterol is activated and forms previtamin D 3 . Previtamin D 3 is then transported to the liver through the bloodstream and hydroxylated into 25 dehydroxyvitamin D. It is then transported to the kidney and hydroxylated again to 1, 25 dihydroxyvitamin D, otherwise known as calcitriol. In this form, it performs its well-known function of calcium homeostasis. When ingested, vitamin D comes in two forms, vitamin D 2 and vitamin D 3 . Both forms are fat-soluble vitamins and are absorbed in the small intestine. Then, the vitamin is transported to the liver and enters the same pathway of hydroxylation as sunlight sources. 12 Of the oral sources, vitamin D 3 has been found to yield 70% higher serum levels than vitamin D 2 ( Fig. 1 ). 26 
Daily Intake
The Institute of Medicine 17 defines the RDA for vitamin intake to maintain vitamin D sufficiency in the United States, and last revised the RDA in 1997. The current recommendations suggest that people get 5 g (200 IU) of vitamin D from infancy to age 50. For those aged 50 -70, it is recommended that intake be increased to 10 g (400 IU), and those over 70 should take 15 g (600 IU). 17, 27 To assess sufficiency, a serum vitamin D level is obtained.
The most reliable method of determining serum vitamin D is the radioimmunoassay. 28 Reference values for sufficiency and levels of deficiency have been defined in the literature, with clinical osteomalacia defined as a serum 25 OH vitamin D Ͻ25 nmol/liter, or 5 ng/ml. 21, 23, 29 Because parathyroid hormone changes have been shown to occur at levels of vitamin D at less than 40 -50 nmol/liter, many studies use 30 -40 nmol/liter, or Ͻ20 ng/ml, as the cutoff for vitamin D deficiency. 7, 16, 21, 30, 31 To meet the required amount of vitamin D, one must gain adequate sun exposure or eat a vitamin D-rich diet. Sun exposure has shown a protective effect in many studies, 13, 14, 21, 32 and 15-30 min of exposure can provide 90 -100% of the RDA of vitamin D. 12 The amount of sun exposure that causes minimal redness of the head and hands, roughly 6% of total body surface area, will yield 600 -1000 IU of vitamin D. 33 There is minimal risk of vitamin D intoxication resulting from overexposure because ultraviolet B rays are turned into the inactive metabolites lumisterol and tachysterol, which do not circulate in the bloodstream. 26 Evidence of sunlight's protective effect was demonstrated by a large global study by Lips et al., 34 who found that postmenopausal women farther from the equator had higher deficiency levels than those close to the equator. The most striking result was that no women in Singapore (latitude: 1 degree) were deficient. Toss et al. 35 demonstrated that artificial sunlight may be an effective modality in maintaining vitamin D levels in sun-deprived people. They demonstrated that homebound elderly who were exposed to artificial ultraviolet radiation once a week for 3 mins maintained their vitamin D levels.
Dietary sources of vitamin D include fish liver oils, the flesh of fatty fish, eggs obtained from hens that have been fortified with vitamin D, and fortified milk and cereal. 17 Zittermann 26 reported that a 100-g edible portion of either eel, salmon, or cod liver oil would satisfy the RDA for vitamin intake for all ages. However, the more commonly consumed foods such as eggs, butter, and milk all give far less than 100 IU. 27 Many populations worldwide do not get enough dietary vitamin D because their diet contains few vitamin D-rich foods and the supplemented foods are not sufficient. A study of 417 women ages 20 -80 in rural Iowa showed that intake of vitamin D from food sources ranged from 70 to 175 IU. Furthermore, this study showed that there was a significant correlation between sun exposure and serum vitamin D levels, but a similar relationship was not found between food intake and serum levels. 36 Many people erroneously believe that drinking milk will meet their vitamin D requirement, but research has shown that milk drinkers have deficiency rates that are similar to those of non-milk drinkers. 20, 21 It has also been shown that taking the RDA of vitamin D from a multivitamin was not protective for the populations at risk. Despite supplementation with 400 IU of multivitamin, 20% of Canadian women aged 18 -35 were deficient in the winter. 21 A study in Denmark lends further support to this idea; 60% of Muslim women with an intake averaging 12 g (500 IU) of vitamin supplementation were still deficient. 19 The above studies are remarkable in that all populations were taking the RDA of vitamin D and still remained deficient, demonstrating that even patients taking vitamin D supplements may still be at risk.
On the other hand, various studies have shown that an intake greater than the RDA of vitamin D in a multivitamin has protective effects. Healthy white women with an average age of 60 remained vitamin D sufficient on 500 IU consumed daily during the winter. 37 Ambulatory nursing home patients showed an increase in vitamin D level of 162% over placebo with treatment of 800 IU of vitamin D 3 . 38 Numerous studies have shown excellent clinical improvement of deficiency on 50,000 IU or more of ergocalciferol per month, with no reported adverse effects (Table 1) . 4, 8, 13 Past work has shown that larger doses of supplementation cannot only be tolerated but are essential to prevent and treat vitamin D deficiency.
At-Risk Populations
Many different populations are at risk for vitamin D deficiency, with a lack of sunlight often the underlying cause. As a result, there has been great interest in comparing serum levels at the end of winter vs. summer and the beginning of fall. 14, 20, 21, 37 These studies would be expected to reflect sunlight's effect on vitamin D because a change in oral intake is unlikely to be seasonally related. In addition, vitamin D absorption from sunlight is reduced during winter because of decreased exposure and the change in the angle of the sun during winter. 33 In tropical countries, the angle of the sun is still adequate in the winter to provide sufficient vitamin D and also to create longer days and climates that are more favorable to direct sunlight exposure. Studies performed at the equator support this idea, with serum vitamin D levels ranging from 107 to 163 nmol/liter found during winter. 26 The young, healthy population across the United States was examined for seasonal differences in vitamin D. These are important studies because medical conditions as cofounders are reduced. These studies include internal medicine residents in Portland with a 52% decrease in winter, 39 healthcare professionals in Boston with a 35% decrease, 20 and adolescents in Bangor, ME with a 48% decrease. 40 Skin pigmentation has also been shown to play an important role in vitamin D deficiency. 7, 14, 22 Melanin, which is found in higher levels in people with more skin pigmentation, blocks the absorption of ultraviolet B rays. Goswani et al. 22 found a dramatic difference between pigmented and depigmented persons. During the winter in Delhi, India, depigmented persons received one fifth the amount of sunlight as others, yet they had significantly higher levels of serum vitamin D. The African American population is at great risk because of the large amount of melanin in their skin. When comparing African American women with white American women, Harris and Dawson-Hughes 14 found that African American women's levels of vitamin D were half those of age-matched white women regardless of season.
Many populations have decreased sun exposure regardless of climate. Cultural reasons play an important role for Muslim women who remain veiled when outside and who, as a result, are at high risk of vitamin D deficiency. Veiled Arab women living in Denmark had an average vitamin D level of 7.1 nmol/liter compared with 47.1 nmol/liter for native Danish women. 19 Elderly people, especially homebound or nursing home patients, are at increased risk because they rarely get sunlight. 13, 15, 16, 32 This is exacerbated by the fact that the elderly have a twofold decrease in the ability to produce previtamin D 3 in the epidermis, placing them at even greater risk to develop deficiency if they do not double their consumption of vitamin D. 41 Gloth et al. 13, 15 found that 48% of homebound elderly were vita- Treatment of vitamin D deficiency resulted in relief of musculoskeletal pain complaints. RCT, randomized controlled trial.
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Vitamin D Deficiency min D deficient, and a surprising 32% of nursing home patients getting the recommended 400 IU of vitamin D were still deficient. Even young healthy people who use sunscreen may be at risk. Sunscreen with a sun protection factor of 8 can eliminate 97.5% of vitamin D absorption from ultraviolet B rays. Those who applied sunscreen 1 hr before ultraviolet B ray exposure did not have any change in vitamin D as opposed to those who did not apply protection. Without any sunscreen, vitamin D levels rose from 1.5-25.6 ng/ml, with only one minimal erythema dose. 42 Because vitamin D is absorbed by the ileum, many gastrointestinal disorders can cause deficiency. Malabsorption syndromes such as Crohn's disease and celiac sprue are important causes, and gastric stapling has also been correlated with vitamin D deficiency. As these weight-reducing procedures are becoming more common, the overall importance of these conditions as a source of vitamin D deficiency is increasing. Clinicians must be aware that vitamin D deficiency should be considered in the differential diagnosis in these patient populations when they present with skeletal symptoms. A study evaluating gastrointestinal disorders validates this point. All 17 subjects with gastrointestinal disorders had serum vitamin D levels less than 15 ng/ml, with 14 of them having levels less than 10. 23 A final population that is considered at risk is those who are obese. Obesity can also cause vitamin D deficiency because the fat-soluble vitamin is stored in fat tissue rather than circulating in the bloodstream. 26 
Musculoskeletal Manifestation
Vitamin D deficiency primarily presents with musculoskeletal complaints and is an early warning of osteomalacia. Osteomalacia is a mineralization defect in the skeleton that presents as diffuse bone pain, polyarthralgias, and muscle weakness affecting the spine, rib cage, shoulders, and hips. 29, 43 As more research ensues, it seems that bone pain and weakness may manifest with minimal vitamin D deficiency. Because these symptoms mirror the most commonly presenting symptoms in musculoskeletal and pain clinics, a more indepth understanding of the populations at risk will help in the diagnosis and treatment of these symptoms early in their progression.
Musculoskeletal Pain
Evidence for the correlation between musculoskeletal pain syndromes and vitamin D deficiency is mounting. Several studies have been reported in the literature illustrating bone pain and/or muscle pain. Ninety-three percent of patients presenting to a community health clinic with nonspecific musculoskeletal pain were found to have vitamin D deficiency. It is remarkable to note that of these patients, 100% under the age of 30 with musculoskeletal complaints were vitamin D deficient, with 55% being severely deficient. 7 Gloth et al. 6 presented five cases of severe lower-leg and back pain as well as hyperesthesia after 6 mos or more of confinement to home or hospital. Al Faraj and Al Mutairi 3 did an extensive study on Muslim patients presenting to internal medicine and spinal clinics with back pain. The study of more than 300 patients showed that 83% of patients had a serum 25 OH vitamin D less than 22.4.
Russell's 9 astute observation that muscle pain is a presenting symptom is evidenced by his extensive case study of 45 patients with exertional thigh pain who underwent biopsy and showed severe type 2 atrophy. Glerup et al. 5, 19 found that 96% of veiled Arab women presenting to a primary health clinic in Denmark were vitamin D deficient, and 88% of them complained of muscle pain. They also reported that 35% complained of proximal muscle weakness, which manifested itself in difficulty rising from a chair and climbing stairs. All of these women were vitamin D deficient, with serum 25-OH vitamin D levels averaging 6.7 nmol/liter.
Muscle weakness has been identified as a symptom of vitamin D deficiency. 5, 8, 11, 23 In a study on gastrointestinal-related vitamin D deficiency, 94% of patients had muscle weakness as well as bone pain for an average of 20 mos before a serum vitamin D was taken. Vitamin D levels were all less than 15 ng/ml, and the mean was a mere 5.4 ng/ml. 23 In the intensive care unit, a patient who had an extended hospitalization was found to have muscle weakness. All studies were normal except for a very low serum vitamin D level of 3.7 nmol/ liter. 11 This and other studies demonstrate the importance of considering vitamin D deficiency in at-risk populations.
Mechanism of Vitamin D-Related Musculoskeletal Symptoms
One proposed pain mechanism is that the insufficient calcium phosphate levels lead to the inability to mineralize the expanding collagen matrix of bone. This rubbery matrix is hydrated and expands, causing an outward pressure under the periosteal covering. This area is richly innervated by sensory pain fibers and senses the increase in pressure as pain. 44 A proposed mechanism for the muscle weakness associated with vitamin D deficiency is that calcidiol binds to vitamin D-dependent receptors in muscle. 18, 45 In vitamin D deficiency, vitamin D-dependent receptors decrease and calcidiol has fewer potential binding sites. Notably, treatment with 1,25 dihydroxyvitamin D, calcitriol, did not show an increase in muscle strength. 46 Therefore, it seems that calcidiol rather than calcitriol is important in maintaining muscle strength. Muscle biopsy studies have further supported this proposed mechanism. In clinical osteomalacia, muscle biopsy shows moderate atrophy in both type I and II fibers. 47 Case studies have shown severe type II muscle atrophy in patients presenting with muscle weakness and pain. 9, 10 An increase in type IIa fiber number and size was shown after treatment with vitamin D. 24 The ramifications of poor muscle strength are often seen in the rehabilitation setting. Past studies have shown that it leads to postural and balance disturbances, contributing to falls and fractures in the elderly. 38, 48, 49 Treatment Numerous case studies have shown improvement of lower-extremity and back pain with the treatment of vitamin D (Table 1) . 3,4,6,8 -10 Al Faraj and Al Mutairi 3 found that 100% of patients with vitamin D deficiency had complete resolution of pain when their vitamin D levels were normalized. However, the study excluded patients with disc prolapse, spinal stenosis, and degenerative disc disease found on CT and MRI. Treatment with 10,000 IU/wk of ergocalciferol intramuscularly and 400 -600 IU/day of ergocalciferol reduced symptoms within one and a half months. 5 Gloth et al. 6 presented five cases of severe lower-leg and back pain and hyperesthesia after 6 mos or more of confinement to home or hospital. The pain was resistant to analgesics but responded to treatment with ergocalciferol. Three studies showed that 50,000 IU/wk of ergocalcieferol improved lower-extremity and back pain and also made the patients independent with walking. 4, 6, 9 If adequate levels of vitamin D are not maintained, the symptoms will return. One patient with leg and foot pain returned 6 mos after successful treatment with ergocalciferol with the same symptoms. She again had low levels of serum 25 OH vitamin D (30 nmol/liter). After repeat treatment, her pain subsided. She ultimately required 1200 IU/day of ergocalciferol. 6 Numerous studies have shown improvements in muscle strength after treatment with 25 OHvitamin D. 9 -11,18,45,50,51 Bischoff-Ferrari et al. 30 found that in both active and nonactive adults, the greater the vitamin D level, the better the person was able to perform on lower-extremity function testing. Activities such as time required to dress, time from sitting to standing, hand grip, and leg extension power have all been shown to correlate with 25-OH vitamin D levels. 24, 30, 45, 51 This was further demonstrated in the third National Health and Nutrition Examination Survey trials, which showed that an increase in vitamin D serum levels from 22.5 to 40 nmol/liter yielded a significant increase in lower-extremity function, tested by timed sit-to-stand and walking tests. 18 Ziambaras and Dagogo-Jack 10 reported two patients with muscle aches and lower-extremity weakness who had undetectable levels of vitamin D but who improved within 2 mos of treatment with 50,000 units of ergocalciferol orally per day.
When assessing a population of long-term care patients in Switzerland, Bischoff et al. 48 found a 50% reduction in the number of falls in elderly patients treated with 400 IU of vitamin D. The same study found a 9% increase in knee extensor strength and an 11% increase in the timed upand-go test.
DISCUSSION
Musculoskeletal pain is commonly seen in the rehabilitation setting. In the inpatient setting, many patients arrive after weeks of hospitalization. They often arrive in poor nutritional status, rarely having taken vitamin D supplementation, and many are homebound before the onset of their illness. As was discussed earlier in this paper, these are populations that are at high risk for vitamin D deficiency. 11, 13, 15, 38, 45 Many of these patients also have nonspecific pain complaints that could, in part, be a result of vitamin D deficiency. Rectifying this problem with early intervention could potentially improve patients' muscle strength and mobility and reduce morbidity from their conditions. 48, 50 It has already been shown that improved muscle strength is correlated with fewer falls and fractures. 38, 48, 49 Outpatient rehabilitation medicine practices should also pay particular attention to vitamin D status when evaluating musculoskeletal pain complaints. Many patients present to the physiatrist after having numerous tests related to their pain or muscle weakness. In particular, vitamin D deficiency should be considered in patients with low-back pain but with no MRI findings, or in healthy patients with leg pain or unexplained proximal weakness.
CONCLUSION
Diagnosis of vitamin D deficiency is rarely made by clinicians in the rehabilitation environment. However, it is precisely this population that may be at particular risk for this diagnosis. Moreover, many of the signs and symptoms that are found in this patient population could, in part, be a result of vitamin D deficiency, and these symptoms might be ameliorated by vitamin D replacement therapy. It is therefore incumbent on physicians to consider this diagnosis in this population, obtain the appropriate diagnostic evaluations, and ensure that appropriate replacement therapy is offered to any patient requiring it. Clinicians should be especially vigilant when treating at-risk populations and should consider screening patients who present with skeletal complaints such as nonspecific muscle pain, bone pain, and muscle weakness.
The rehabilitation setting is the ideal setting to study vitamin D deficiency. Further research is needed to address the prevalence of vitamin D deficiency in the pain population, including those that have MRI findings such as spinal stenosis and degenerative disc disease. The inpatient rehabilitation population could also be invaluable in determining the effect of vitamin D deficiency on muscle strength, pain, and recovery from extended hospitalization. The effect of replacement therapy in this population could also shed considerable light on the potential functional benefit that could result from the proper diagnosis and treatment of vitamin D deficiency.
